Related Experiment Video
Updated: Aug 14, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
Change in oligomerization specificity of the p53 tetramerization domain by hydrophobic amino acid substitutions
E S Stavridi1, N H Chehab, L C Caruso
1Programs in Molecular Genetics and Structural Biology, The Wistar Institute, Philadelphia, Pennsylvania 19104-4268, USA.
Abstract:
The tumor suppressor function of the wild-type p53 protein is transdominantly inhibited by tumor-derived mutant p53 proteins. Such transdominant inhibition limits the prospects for gene therapy approaches that aim to introduce wild-type p53 into cancer cells. The molecular mechanism for transdominant inhibition involves sequestration of wild-type p53 subunits into inactive wild-type/mutant hetero-tetramers. Thus, p53 proteins, whose oligomerization specificity is altered so they cannot interact with tumor-derived mutant p53, would escape transdominant inhibition. Aided by the known three-dimensional structure of the p53 tetramerization domain and by trial and error we designed a novel domain with seven amino acid substitutions in the hydrophobic core. A full-length p53 protein bearing this novel domain formed homo-tetramers and had tumor suppressor function, but did not hetero-oligomerize with tumor-derived mutant p53 and resisted transdominant inhibition. Thus, hydrophobic core residues influence the oligomerization specificity of the p53 tetramerization domain.
Insights
Mutant p53 proteins inhibit wild-type p53
Area of Science:
- Molecular Biology
- Cancer Research
- Protein Structure
Background:
- Wild-type p53 protein's tumor suppressor function is inhibited by mutant p53.
- This transdominant inhibition hinders gene therapy for cancer.
Purpose of the Study:
- To design a modified p53 protein that evades transdominant inhibition by mutant p53.
- To investigate the role of hydrophobic core residues in p53 tetramerization specificity.
Main Methods:
- Utilized the known 3D structure of the p53 tetramerization domain.
- Employed trial-and-error to design a novel tetramerization domain with seven amino acid substitutions in the hydrophobic core.
- Constructed and tested full-length p53 protein variants.
Main Results:
- A novel p53 tetramerization domain was designed with seven amino acid substitutions.
- The modified p53 protein formed homo-tetramers and retained tumor suppressor function.
- This modified p53 did not hetero-oligomerize with mutant p53 and resisted transdominant inhibition.
Conclusions:
- Hydrophobic core residues critically influence p53 tetramerization specificity.
- Engineered p53 variants can overcome transdominant inhibition, offering potential therapeutic strategies.
More Related Videos
11:27X-Ray Crystallography to Study the Oligomeric State Transition of the Thermotoga maritima M42 Aminopeptidase TmPep1050
Published on: May 13, 2020
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Protein Folding
Conserved Binding Sites
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cooperative Allosteric Transitions
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Abnormal Proliferation
Protein Folding
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...